What is Livtencity?
Livtencity is the brand name for a medicine called maribavir, used to treat cytomegalovirus (CMV) infection in certain patients after a transplant. [1]
Who is Livtencity for?
Livtencity is intended for people with CMV infection who are transplant recipients and where prior treatments have not worked or are not tolerated, based on the approved use described for maribavir. [1]
What does maribavir (Livtencity) do?
Maribavir works by targeting CMV replication inside cells through a mechanism related to CMV’s protein kinase activity (maribavir inhibits CMV UL97). This helps control viral activity in CMV infection. [1]
How is Livtencity taken?
The exact dosing schedule depends on the indication and patient factors (such as kidney or liver function) and follows the prescribing information and clinician direction. [1]
What side effects are associated with Livtencity?
Commonly reported side effects vary by study and patient population, but they can include symptoms such as taste disturbances and gastrointestinal effects, among others, depending on the source and regimen. [1]
Is Livtencity the same as other CMV drugs (like valganciclovir or letermovir)?
No. Livtencity (maribavir) is a different drug class and is used for specific CMV situations after transplant. Other CMV medicines (for example, antivirals used for prevention or treatment) target different steps of viral replication and are used under different clinical circumstances. [1]
Where can I find official prescribing information?
You can review the official prescribing details for Livtencity through the product’s labeling and regulatory documentation available via the manufacturer or the relevant health authority database. [1]
Sources
[1] https://www.accessdata.fda.gov/